- Report
- January 2026
- 550 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- January 2026
- 280 Pages
Global
From €2689EUR$3,000USD£2,307GBP
- Report
- May 2026
- 400 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- May 2026
- 350 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- May 2026
- 350 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- May 2026
- 350 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- May 2026
- 400 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- May 2026
- 350 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- May 2026
- 165 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 148 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 145 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 158 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- April 2026
- 157 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- January 2026
- 128 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- January 2026
- 140 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- August 2025
- 154 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- April 2026
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- September 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- September 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- January 2026
- 160 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more